Erasca
ERAS· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock +48.2% in FY2025
Jonathan E. Lim, M.D. is the CEO of Erasca and was paid $4.3M in FY2025 (Dec), up 10%.
Pay$100 in the stock at the end of FY21 → $24
Executives3
See all- 1Jonathan E. Lim, M.D.Chairman, Chief Executive Officer, and Co-FounderFY2025
- 2David M. Chacko, M.D.Chief Financial Officer and Chief Business OfficerFY2025
- 3Shannon R. Morris, M.D., Ph.D.Chief Medical OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allErasca paid its 3 named executives $7.8M in total in FY2025 (Dec). CEO Jonathan E. Lim, M.D. was paid $4.3M of that.
| Name | |||
|---|---|---|---|
| Jonathan E. Lim, M.D.Chairman, Chief Executive Officer, and Co-Founder | |||
| David M. Chacko, M.D.Chief Financial Officer and Chief Business Officer | |||
| Shannon R. Morris, M.D., Ph.D.Chief Medical Officer | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Erasca. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 28, 2026 | FY2025 |
| Annual report | 10-K | Mar 12, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 29, 2025 | FY2024 |
| Annual report | 10-K | Mar 20, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 26, 2024 | FY2023 |
| Annual report | 10-K | Mar 27, 2024 | FY2023 |
